Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassinelli

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Biochemical Pharmacology|June 12, 2020
Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunitiesCinzia Lanzi, Giuliana Cassinelli
Il Giornale Di Chirurgia|June 1, 1991
[The surgical therapy of morbid obesity: our experience]G B Cassinelli, P Fenaroli
Journal of Medicinal Chemistry|January 1, 1987
Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptorsC Melchiorre, A Cassinelli, W Quaglia
Journal of Biomedical Materials Research|August 1, 1997
Reduced plaque accumulation on hydrocarbon thin film deposited on restorative acrylic polymersM Bellanda, C Cassinelli, M Morra
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Minerva Medica|January 28, 1980
[Reimplantation of the areola and nipple in mastectomy operations for breast carcinoma]M Bocca, T Cassinelli, U Crovella
Current Medicinal Chemistry|February 21, 2017
Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug ResistanceCinzia Lanzi, Nadia Zaffaroni, Giuliana Cassinelli
Medical Device Technology|March 8, 1997
Surface-modified polyester fabricsP Canonico, C Cassinelli, M Morra
Cancer Letters|September 27, 2016
The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomasGiuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi
Frontiers in Oncology|September 19, 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversGiuliana Cassinelli, Sandro Pasquali, Cinzia Lanzi
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Biochemical Pharmacology|June 12, 2020
Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunitiesCinzia Lanzi, Giuliana Cassinelli
Il Giornale Di Chirurgia|June 1, 1991
[The surgical therapy of morbid obesity: our experience]G B Cassinelli, P Fenaroli
Journal of Medicinal Chemistry|January 1, 1987
Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptorsC Melchiorre, A Cassinelli, W Quaglia
Journal of Biomedical Materials Research|August 1, 1997
Reduced plaque accumulation on hydrocarbon thin film deposited on restorative acrylic polymersM Bellanda, C Cassinelli, M Morra
Advances in Experimental Medicine and Biology|April 11, 2020
Non-Anticoagulant Heparins as Heparanase InhibitorsGiuseppe Cassinelli, Giangiacomo Torri, Annamaria Naggi
Minerva Medica|January 28, 1980
[Reimplantation of the areola and nipple in mastectomy operations for breast carcinoma]M Bocca, T Cassinelli, U Crovella
Current Medicinal Chemistry|February 21, 2017
Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug ResistanceCinzia Lanzi, Nadia Zaffaroni, Giuliana Cassinelli
Medical Device Technology|March 8, 1997
Surface-modified polyester fabricsP Canonico, C Cassinelli, M Morra
Cancer Letters|September 27, 2016
The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomasGiuliana Cassinelli, Nadia Zaffaroni, Cinzia Lanzi
Frontiers in Oncology|September 19, 2022
Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression driversGiuliana Cassinelli, Sandro Pasquali, Cinzia Lanzi
Pageof 35